| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.10B | 975.18M | 766.89M | 595.34M | 425.49M |
| Gross Profit | 425.20M | 395.96M | 250.87M | 186.03M | 162.15M |
| EBITDA | 171.76M | 133.40M | 41.10M | -15.72M | 5.82M |
| Net Income | 139.14M | 46.92M | -33.61M | -59.49M | -29.70M |
Balance Sheet | |||||
| Total Assets | 1.78B | 1.57B | 1.46B | 1.13B | 784.41M |
| Cash, Cash Equivalents and Short-Term Investments | 277.98M | 268.63M | 296.87M | 132.74M | 72.79M |
| Total Debt | 560.01M | 424.09M | 425.06M | 5.71M | 7.09M |
| Total Liabilities | 569.12M | 519.52M | 510.97M | 93.81M | 64.66M |
| Stockholders Equity | 1.21B | 1.06B | 953.45M | 1.03B | 719.75M |
Cash Flow | |||||
| Free Cash Flow | 12.38M | -32.80M | -163.15M | -273.30M | -321.45M |
| Operating Cash Flow | 160.56M | 154.29M | 75.94M | -43.23M | 647.00K |
| Investing Cash Flow | -148.18M | -187.09M | -239.09M | -233.36M | -322.10M |
| Financing Cash Flow | -3.04M | 4.57M | 327.29M | 336.54M | 326.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $4.14B | 32.91 | 12.29% | ― | 16.34% | 177.51% | |
65 Neutral | $2.20B | 16.00 | 10.38% | ― | -2.23% | 57.16% | |
64 Neutral | $1.66B | 27.73 | 6.60% | 3.53% | 0.54% | -24.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | $1.58B | 19.01 | 5.17% | ― | 8.98% | -26.29% | |
62 Neutral | $1.61B | 10.66 | 5.41% | 5.40% | 1.44% | 8.29% | |
61 Neutral | $12.37B | ― | -20.68% | 4.45% | -0.66% | -326.55% |
Freshpet reported strong fourth quarter and full-year 2025 results on February 23, 2026, highlighted by net sales of $285.2 million for the quarter, up 8.6% year over year, and $1.1 billion for the full year, up 13%, marking the company’s first time surpassing the $1 billion sales threshold. Profitability improved with full-year net income jumping to $139.1 million from $46.9 million, adjusted EBITDA rising to $195.7 million, and free cash flow turning positive at $12.4 million, supported by better gross margins, tighter SG&A leverage and sustained volume-led growth.
Management pointed to lessons from 2025 and a revamped marketing model, growing e-commerce momentum, tests of higher-visibility “island fridges,” and the startup of a new manufacturing line using breakthrough technology as key strategic advances. For 2026, Freshpet guided to net sales growth of 7%–10%, adjusted EBITDA of $205 million–$215 million, and continued positive free cash flow alongside about $150 million in capital expenditures, signaling ongoing investment in capacity while targeting further margin and cash generation gains for investors and other stakeholders.
The most recent analyst rating on (FRPT) stock is a Buy with a $79.00 price target. To see the full list of analyst forecasts on Freshpet stock, see the FRPT Stock Forecast page.
On February 4, 2026, Freshpet announced a leadership reshuffle designed to bolster its finance and supply chain capabilities, appointing John O’Connor as Chief Financial Officer effective February 9, 2026, and Ana Lopez as Senior Vice President of Supply Chain effective February 2, 2026. O’Connor, a veteran of Zoetis and former CFO of Thrive Pet Healthcare, succeeds interim CFO Ivan Garcia, who returns to his prior focus as Senior Vice President of Finance, and receives a compensation package that includes salary, bonus and long-term equity incentives, alongside a grant of 7,500 time-vested restricted stock units. Lopez, a seasoned supply chain executive from Unilever and Johnson & Johnson, is expected to strengthen Freshpet’s end-to-end operations as the company seeks to support its mission of fresh pet nutrition and its next phase of growth, while the reaffirmation of its 2025 outlook suggests management confidence in its current strategic trajectory despite the leadership transition.
The most recent analyst rating on (FRPT) stock is a Buy with a $79.00 price target. To see the full list of analyst forecasts on Freshpet stock, see the FRPT Stock Forecast page.
On December 8, 2025, Freshpet, Inc.’s Board of Directors approved a 2025 Retention Grant for COO Nicola Baty, consisting of Restricted Stock Units (RSUs) to address decreased valuation of her initial equity package. The grant aims to reinforce retention, focus on long-term performance, and align leadership with shareholder interests, with vesting conditions tied to continued employment and company performance goals.
The most recent analyst rating on (FRPT) stock is a Hold with a $68.00 price target. To see the full list of analyst forecasts on Freshpet stock, see the FRPT Stock Forecast page.